nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—Gefitinib—Lapatinib—breast cancer	0.474	1	CrCrCtD
Minaprine—ACHE—breast cancer	0.239	0.756	CbGaD
Minaprine—CYP2D6—breast cancer	0.0771	0.244	CbGaD
Minaprine—HTR2B—Raloxifene—breast cancer	0.061	0.418	CbGbCtD
Minaprine—ACHE—Irinotecan—breast cancer	0.0419	0.287	CbGbCtD
Minaprine—CYP2D6—Idarubicin—breast cancer	0.0178	0.122	CbGbCtD
Minaprine—CYP2D6—Vinorelbine—breast cancer	0.00872	0.0597	CbGbCtD
Minaprine—CYP2D6—Tamoxifen—breast cancer	0.00787	0.0539	CbGbCtD
Minaprine—CYP2D6—Vinblastine—breast cancer	0.00537	0.0368	CbGbCtD
Minaprine—CYP2D6—Doxorubicin—breast cancer	0.0033	0.0226	CbGbCtD
Minaprine—Gefitinib—CHEK2—breast cancer	0.0007	0.267	CrCbGaD
Minaprine—Gefitinib—ERBB3—breast cancer	0.000624	0.238	CrCbGaD
Minaprine—Gefitinib—EGFR—breast cancer	0.00028	0.107	CrCbGaD
Minaprine—Moclobemide—CYP2D6—breast cancer	0.000254	0.0972	CrCbGaD
Minaprine—Gefitinib—ABCG2—breast cancer	0.000204	0.0781	CrCbGaD
Minaprine—Gefitinib—CYP1A1—breast cancer	0.00016	0.0611	CrCbGaD
Minaprine—Gefitinib—CYP2D6—breast cancer	0.000119	0.0455	CrCbGaD
Minaprine—MAOA—nipple—breast cancer	0.000116	0.0525	CbGeAlD
Minaprine—ACHE—adrenal gland—breast cancer	0.000104	0.0468	CbGeAlD
Minaprine—Gefitinib—CYP3A4—breast cancer	0.000102	0.039	CrCbGaD
Minaprine—MAOA—embryo—breast cancer	9.6e-05	0.0433	CbGeAlD
Minaprine—HTR2B—skin of body—breast cancer	9.1e-05	0.0411	CbGeAlD
Minaprine—Gefitinib—ALB—breast cancer	8.91e-05	0.034	CrCbGaD
Minaprine—HTR2B—endometrium—breast cancer	8.58e-05	0.0387	CbGeAlD
Minaprine—Gefitinib—ABCB1—breast cancer	8.5e-05	0.0325	CrCbGaD
Minaprine—HTR2B—uterus—breast cancer	7.91e-05	0.0357	CbGeAlD
Minaprine—HTR2B—adipose tissue—breast cancer	7.73e-05	0.0349	CbGeAlD
Minaprine—HTR2C—female reproductive system—breast cancer	7.57e-05	0.0342	CbGeAlD
Minaprine—SLC6A4—female reproductive system—breast cancer	7.17e-05	0.0324	CbGeAlD
Minaprine—CHRM1—female reproductive system—breast cancer	7.14e-05	0.0323	CbGeAlD
Minaprine—HTR2B—female reproductive system—breast cancer	7.11e-05	0.0321	CbGeAlD
Minaprine—MAOA—endometrium—breast cancer	7.02e-05	0.0317	CbGeAlD
Minaprine—HTR2B—adrenal gland—breast cancer	6.94e-05	0.0313	CbGeAlD
Minaprine—MAOA—uterus—breast cancer	6.47e-05	0.0292	CbGeAlD
Minaprine—MAOA—pituitary gland—breast cancer	6.35e-05	0.0287	CbGeAlD
Minaprine—MAOA—adipose tissue—breast cancer	6.33e-05	0.0286	CbGeAlD
Minaprine—DRD2—pituitary gland—breast cancer	6.29e-05	0.0284	CbGeAlD
Minaprine—HTR2A—embryo—breast cancer	6.26e-05	0.0283	CbGeAlD
Minaprine—ACHE—lymph node—breast cancer	6.21e-05	0.028	CbGeAlD
Minaprine—SLC6A4—endocrine gland—breast cancer	6.07e-05	0.0274	CbGeAlD
Minaprine—CHRM1—endocrine gland—breast cancer	6.05e-05	0.0273	CbGeAlD
Minaprine—MAOA—female reproductive system—breast cancer	5.82e-05	0.0263	CbGeAlD
Minaprine—MAOA—adrenal gland—breast cancer	5.68e-05	0.0256	CbGeAlD
Minaprine—MAOA—female gonad—breast cancer	5.29e-05	0.0239	CbGeAlD
Minaprine—HTR2A—epithelium—breast cancer	5.11e-05	0.0231	CbGeAlD
Minaprine—MAOA—endocrine gland—breast cancer	4.92e-05	0.0222	CbGeAlD
Minaprine—DRD2—endocrine gland—breast cancer	4.87e-05	0.022	CbGeAlD
Minaprine—HTR2B—lymph node—breast cancer	4.16e-05	0.0188	CbGeAlD
Minaprine—HTR2A—pituitary gland—breast cancer	4.15e-05	0.0187	CbGeAlD
Minaprine—HTR2A—female reproductive system—breast cancer	3.79e-05	0.0171	CbGeAlD
Minaprine—HTR2A—adrenal gland—breast cancer	3.7e-05	0.0167	CbGeAlD
Minaprine—CYP2D6—female reproductive system—breast cancer	3.46e-05	0.0156	CbGeAlD
Minaprine—MAOA—lymph node—breast cancer	3.4e-05	0.0154	CbGeAlD
Minaprine—HTR2A—endocrine gland—breast cancer	3.21e-05	0.0145	CbGeAlD
Minaprine—CYP2D6—female gonad—breast cancer	3.15e-05	0.0142	CbGeAlD
Minaprine—CYP2D6—endocrine gland—breast cancer	2.93e-05	0.0132	CbGeAlD
Minaprine—HTR2B—Signaling by GPCR—IL6—breast cancer	2.48e-06	4.21e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—APC—breast cancer	2.46e-06	4.19e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—KIT—breast cancer	2.46e-06	4.19e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CG—breast cancer	2.46e-06	4.19e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CXCL8—breast cancer	2.46e-06	4.17e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—KRAS—breast cancer	2.46e-06	4.17e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EGF—breast cancer	2.45e-06	4.16e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—HRAS—breast cancer	2.44e-06	4.15e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ABCB1—breast cancer	2.44e-06	4.14e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EGF—breast cancer	2.44e-06	4.14e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CCND1—breast cancer	2.43e-06	4.12e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—JUN—breast cancer	2.42e-06	4.11e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—MAPK3—breast cancer	2.41e-06	4.1e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CTNNB1—breast cancer	2.4e-06	4.08e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CDKN1B—breast cancer	2.4e-06	4.08e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—TYMS—breast cancer	2.39e-06	4.07e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—MAPK3—breast cancer	2.37e-06	4.03e-05	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—AKT1—breast cancer	2.37e-06	4.03e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NOS3—breast cancer	2.37e-06	4.03e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—BRAF—breast cancer	2.37e-06	4.02e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.37e-06	4.02e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—NCOR1—breast cancer	2.37e-06	4.02e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GSTM1—breast cancer	2.37e-06	4.02e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—MAPK3—breast cancer	2.36e-06	4.01e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MMP9—breast cancer	2.36e-06	4e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CASP3—breast cancer	2.35e-06	3.99e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IL2—breast cancer	2.35e-06	3.99e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CDKN1A—breast cancer	2.35e-06	3.99e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PTEN—breast cancer	2.34e-06	3.98e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—IL6—breast cancer	2.34e-06	3.97e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—BRAF—breast cancer	2.33e-06	3.96e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—BRAF—breast cancer	2.32e-06	3.94e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IGF1—breast cancer	2.31e-06	3.92e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AKT2—breast cancer	2.3e-06	3.92e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—EGFR—breast cancer	2.29e-06	3.9e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MAPK8—breast cancer	2.29e-06	3.89e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CCND1—breast cancer	2.29e-06	3.89e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—AKT1—breast cancer	2.28e-06	3.88e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—JUN—breast cancer	2.28e-06	3.88e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IGF1—breast cancer	2.27e-06	3.86e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AKT2—breast cancer	2.27e-06	3.85e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CTNNB1—breast cancer	2.27e-06	3.85e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GPX1—breast cancer	2.27e-06	3.85e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—EGFR—breast cancer	2.26e-06	3.84e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IGF1—breast cancer	2.26e-06	3.83e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—PIK3CA—breast cancer	2.26e-06	3.83e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AKT2—breast cancer	2.26e-06	3.83e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MDM2—breast cancer	2.25e-06	3.82e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—EGFR—breast cancer	2.25e-06	3.82e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CYP1A1—breast cancer	2.24e-06	3.81e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—RAF1—breast cancer	2.24e-06	3.81e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—RELA—breast cancer	2.23e-06	3.79e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ERCC2—breast cancer	2.22e-06	3.78e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MMP9—breast cancer	2.22e-06	3.78e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ERBB2—breast cancer	2.22e-06	3.77e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CD—breast cancer	2.21e-06	3.76e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CDKN1A—breast cancer	2.21e-06	3.76e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PTEN—breast cancer	2.21e-06	3.75e-05	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—PIK3CA—breast cancer	2.19e-06	3.73e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SERPINE1—breast cancer	2.19e-06	3.72e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MTOR—breast cancer	2.19e-06	3.72e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CB—breast cancer	2.19e-06	3.72e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CD—breast cancer	2.18e-06	3.7e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—SRC—breast cancer	2.17e-06	3.69e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—KRAS—breast cancer	2.17e-06	3.68e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CD—breast cancer	2.17e-06	3.68e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MAPK8—breast cancer	2.16e-06	3.67e-05	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—PIK3CA—breast cancer	2.16e-06	3.67e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—AKT1—breast cancer	2.15e-06	3.66e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SERPINE1—breast cancer	2.15e-06	3.66e-05	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	2.15e-06	3.65e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SERPINE1—breast cancer	2.14e-06	3.64e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—KRAS—breast cancer	2.13e-06	3.62e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—KRAS—breast cancer	2.12e-06	3.6e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—VEGFA—breast cancer	2.12e-06	3.59e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CXCL8—breast cancer	2.1e-06	3.57e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—STAT3—breast cancer	2.09e-06	3.56e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—MTHFR—breast cancer	2.09e-06	3.55e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NOS3—breast cancer	2.09e-06	3.55e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—HRAS—breast cancer	2.09e-06	3.55e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NOS3—breast cancer	2.06e-06	3.5e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CDKN1B—breast cancer	2.05e-06	3.49e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—SRC—breast cancer	2.05e-06	3.48e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NOS3—breast cancer	2.05e-06	3.48e-05	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—AKT1—breast cancer	2.03e-06	3.45e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CASP3—breast cancer	2.01e-06	3.42e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL2—breast cancer	2.01e-06	3.41e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MAPK3—breast cancer	2e-06	3.4e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PIK3CA—breast cancer	2e-06	3.4e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—IL6—breast cancer	2e-06	3.4e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—VEGFA—breast cancer	1.99e-06	3.39e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—PIK3CA—breast cancer	1.99e-06	3.38e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MDM2—breast cancer	1.98e-06	3.37e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—RAF1—breast cancer	1.98e-06	3.36e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—STAT3—breast cancer	1.98e-06	3.36e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—RELA—breast cancer	1.97e-06	3.34e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—PIK3CA—breast cancer	1.96e-06	3.33e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CCND1—breast cancer	1.96e-06	3.33e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ERBB2—breast cancer	1.96e-06	3.32e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—JUN—breast cancer	1.95e-06	3.32e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MDM2—breast cancer	1.95e-06	3.32e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	1.95e-06	3.31e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MYC—breast cancer	1.95e-06	3.31e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—RAF1—breast cancer	1.94e-06	3.3e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TGFB1—breast cancer	1.94e-06	3.3e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MDM2—breast cancer	1.94e-06	3.3e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CTNNB1—breast cancer	1.94e-06	3.29e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—RELA—breast cancer	1.94e-06	3.29e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—RAF1—breast cancer	1.93e-06	3.29e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CB—breast cancer	1.93e-06	3.28e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MTOR—breast cancer	1.93e-06	3.28e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CAV1—breast cancer	1.93e-06	3.28e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—RELA—breast cancer	1.93e-06	3.27e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ERBB2—breast cancer	1.92e-06	3.27e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ERBB2—breast cancer	1.91e-06	3.25e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—EGFR—breast cancer	1.9e-06	3.23e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MMP9—breast cancer	1.9e-06	3.23e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MTOR—breast cancer	1.9e-06	3.23e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CB—breast cancer	1.9e-06	3.23e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CDKN1A—breast cancer	1.89e-06	3.22e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PTEN—breast cancer	1.89e-06	3.21e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MTOR—breast cancer	1.89e-06	3.21e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CB—breast cancer	1.89e-06	3.21e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MAPK3—breast cancer	1.89e-06	3.21e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PIK3CA—breast cancer	1.89e-06	3.2e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CXCL8—breast cancer	1.85e-06	3.15e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MAPK8—breast cancer	1.85e-06	3.14e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—AKT1—breast cancer	1.84e-06	3.13e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—HRAS—breast cancer	1.84e-06	3.13e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MYC—breast cancer	1.84e-06	3.12e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TGFB1—breast cancer	1.83e-06	3.11e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CXCL8—breast cancer	1.82e-06	3.1e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CXCL8—breast cancer	1.81e-06	3.08e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—HRAS—breast cancer	1.81e-06	3.08e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CDKN1B—breast cancer	1.81e-06	3.08e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—HRAS—breast cancer	1.8e-06	3.06e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—KRAS—breast cancer	1.8e-06	3.06e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—EGFR—breast cancer	1.8e-06	3.05e-05	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—AKT1—breast cancer	1.79e-06	3.04e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CDKN1B—breast cancer	1.78e-06	3.03e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CASP3—breast cancer	1.77e-06	3.02e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CDKN1B—breast cancer	1.77e-06	3.01e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL2—breast cancer	1.77e-06	3.01e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—IL6—breast cancer	1.76e-06	3e-05	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—AKT1—breast cancer	1.76e-06	3e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CG—breast cancer	1.76e-06	2.99e-05	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—AKT1—breast cancer	1.75e-06	2.98e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—SRC—breast cancer	1.75e-06	2.98e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CASP3—breast cancer	1.75e-06	2.97e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL2—breast cancer	1.74e-06	2.96e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CASP3—breast cancer	1.74e-06	2.95e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—IL6—breast cancer	1.74e-06	2.95e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL2—breast cancer	1.73e-06	2.95e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCND1—breast cancer	1.73e-06	2.94e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—IL6—breast cancer	1.73e-06	2.93e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—JUN—breast cancer	1.72e-06	2.93e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CTNNB1—breast cancer	1.71e-06	2.91e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—VEGFA—breast cancer	1.71e-06	2.9e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCND1—breast cancer	1.7e-06	2.89e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—JUN—breast cancer	1.7e-06	2.88e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—KRAS—breast cancer	1.7e-06	2.88e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCND1—breast cancer	1.69e-06	2.87e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—STAT3—breast cancer	1.69e-06	2.87e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—JUN—breast cancer	1.69e-06	2.87e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CTNNB1—breast cancer	1.68e-06	2.86e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MMP9—breast cancer	1.68e-06	2.85e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CTNNB1—breast cancer	1.67e-06	2.85e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CDKN1A—breast cancer	1.67e-06	2.84e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PTEN—breast cancer	1.67e-06	2.83e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PIK3CA—breast cancer	1.65e-06	2.81e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MMP9—breast cancer	1.65e-06	2.8e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CDKN1A—breast cancer	1.64e-06	2.79e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MMP9—breast cancer	1.64e-06	2.79e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PTEN—breast cancer	1.64e-06	2.79e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CDKN1A—breast cancer	1.64e-06	2.78e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—AKT1—breast cancer	1.63e-06	2.78e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PTEN—breast cancer	1.63e-06	2.77e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MAPK8—breast cancer	1.63e-06	2.77e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—AKT1—breast cancer	1.63e-06	2.76e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MAPK3—breast cancer	1.61e-06	2.74e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MAPK8—breast cancer	1.61e-06	2.73e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—AKT1—breast cancer	1.6e-06	2.72e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TP53—breast cancer	1.6e-06	2.72e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MAPK8—breast cancer	1.6e-06	2.71e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—AKT1—breast cancer	1.59e-06	2.71e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MYC—breast cancer	1.57e-06	2.67e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TGFB1—breast cancer	1.57e-06	2.66e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PIK3CA—breast cancer	1.56e-06	2.65e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SRC—breast cancer	1.55e-06	2.63e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.54e-06	2.62e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—AKT1—breast cancer	1.54e-06	2.62e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—EGFR—breast cancer	1.54e-06	2.61e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HRAS—breast cancer	1.53e-06	2.6e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ALB—breast cancer	1.52e-06	2.59e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SRC—breast cancer	1.52e-06	2.59e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SRC—breast cancer	1.51e-06	2.57e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TP53—breast cancer	1.51e-06	2.56e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—VEGFA—breast cancer	1.51e-06	2.56e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—STAT3—breast cancer	1.49e-06	2.53e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—VEGFA—breast cancer	1.48e-06	2.52e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—VEGFA—breast cancer	1.47e-06	2.5e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—STAT3—breast cancer	1.47e-06	2.49e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IL6—breast cancer	1.46e-06	2.49e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—STAT3—breast cancer	1.46e-06	2.48e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—NOS3—breast cancer	1.46e-06	2.48e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—KRAS—breast cancer	1.45e-06	2.47e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HRAS—breast cancer	1.44e-06	2.45e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MAPK3—breast cancer	1.42e-06	2.42e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MAPK3—breast cancer	1.4e-06	2.38e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MAPK3—breast cancer	1.39e-06	2.37e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MYC—breast cancer	1.39e-06	2.35e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TGFB1—breast cancer	1.38e-06	2.35e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IL6—breast cancer	1.38e-06	2.34e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MYC—breast cancer	1.36e-06	2.32e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TGFB1—breast cancer	1.36e-06	2.31e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MYC—breast cancer	1.36e-06	2.3e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—EGFR—breast cancer	1.36e-06	2.3e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TGFB1—breast cancer	1.35e-06	2.3e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—AKT1—breast cancer	1.35e-06	2.29e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.35e-06	2.29e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTGS2—breast cancer	1.33e-06	2.27e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EGFR—breast cancer	1.33e-06	2.27e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	1.33e-06	2.27e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EGFR—breast cancer	1.33e-06	2.25e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TP53—breast cancer	1.29e-06	2.19e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—KRAS—breast cancer	1.28e-06	2.18e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—AKT1—breast cancer	1.27e-06	2.16e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—KRAS—breast cancer	1.26e-06	2.14e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—KRAS—breast cancer	1.25e-06	2.13e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HRAS—breast cancer	1.23e-06	2.1e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL6—breast cancer	1.18e-06	2.01e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CA—breast cancer	1.18e-06	2e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTEN—breast cancer	1.16e-06	1.98e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CA—breast cancer	1.16e-06	1.97e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CA—breast cancer	1.15e-06	1.96e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TP53—breast cancer	1.14e-06	1.93e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TP53—breast cancer	1.12e-06	1.9e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TP53—breast cancer	1.11e-06	1.89e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AKT1—breast cancer	1.09e-06	1.85e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HRAS—breast cancer	1.09e-06	1.85e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HRAS—breast cancer	1.07e-06	1.82e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HRAS—breast cancer	1.07e-06	1.81e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL6—breast cancer	1.04e-06	1.77e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL6—breast cancer	1.03e-06	1.74e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL6—breast cancer	1.02e-06	1.73e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AKT1—breast cancer	9.61e-07	1.63e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AKT1—breast cancer	9.46e-07	1.61e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AKT1—breast cancer	9.41e-07	1.6e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CA—breast cancer	8.21e-07	1.39e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—AKT1—breast cancer	6.7e-07	1.14e-05	CbGpPWpGaD
